
Submit rationality and desirability of Rizatriptan plus Naproxen: CDSCO Panel Tells Akum Drugs and Pharmaceutical
New Delhi: Noting that the firm did not present adequate justification/rationale for the proposed fixed-dose combination (FDC) of rizatriptan benzoate plus naproxen sodium USP (5mg + 550mg and 10mg + 550mg) film-coated tablets, the Subject Expert …